Header Logo

Connection

Renate Strehlau to South Africa

This is a "connection" page, showing publications Renate Strehlau has written about South Africa.
Connection Strength

1,058
  1. Outcomes of newborn hearing screening at an academic secondary level hospital in Johannesburg, South Africa. S Afr J Commun Disord. 2021 Jan 27; 68(1):e1-e8.
    View in: PubMed
    Score: 0,073
  2. Neurodevelopment in early treated HIV-infected infants participating in a developmental stimulation programme compared with controls. Child Care Health Dev. 2021 03; 47(2):154-162.
    View in: PubMed
    Score: 0,072
  3. A description of early neurodevelopment in a cohort of HIV-exposed uninfected children. AIDS Care. 2020 11; 32(11):1421-1428.
    View in: PubMed
    Score: 0,068
  4. Substituting Abacavir for Stavudine in Children Who Are Virally Suppressed Without Lipodystrophy: Randomized Clinical Trial in Johannesburg, South Africa. J Pediatric Infect Dis Soc. 2018 Aug 17; 7(3):e70-e77.
    View in: PubMed
    Score: 0,061
  5. Neurodevelopmental assessment of HIV-exposed uninfected and early-treated HIV-infected children: study protocol. BMC Res Notes. 2018 Apr 06; 11(1):235.
    View in: PubMed
    Score: 0,060
  6. HIV-associated neurodevelopmental delay: prevalence, predictors and persistence in relation to antiretroviral therapy initiation and viral suppression. Child Care Health Dev. 2016 11; 42(6):881-889.
    View in: PubMed
    Score: 0,054
  7. Developmental status of preschool children receiving cART: a descriptive cohort study. Child Care Health Dev. 2016 May; 42(3):410-4.
    View in: PubMed
    Score: 0,052
  8. Lipid profiles in young HIV-infected children initiating and changing antiretroviral therapy. J Acquir Immune Defic Syndr. 2012 Aug 01; 60(4):369-76.
    View in: PubMed
    Score: 0,040
  9. Absence seizures associated with efavirenz initiation. Pediatr Infect Dis J. 2011 Nov; 30(11):1001-3.
    View in: PubMed
    Score: 0,038
  10. Pharmacokinetics and safety of coformulated bictegravir, emtricitabine, and tenofovir alafenamide in children aged 2 years and older with virologically suppressed HIV: a phase 2/3, open-label, single-arm study. Lancet HIV. 2024 May; 11(5):e300-e308.
    View in: PubMed
    Score: 0,023
  11. Growth Trajectories Over the First Year of Life Among Early-Treated Infants with Human Immunodeficiency Virus and Infants Who are Human Immunodeficiency Virus-Exposed Uninfected. J Pediatr. 2024 Jul; 270:114018.
    View in: PubMed
    Score: 0,023
  12. Microbiota in the oral cavity of school-age children with HIV who started antiretroviral therapy at young ages in South Africa. AIDS. 2023 08 01; 37(10):1583-1591.
    View in: PubMed
    Score: 0,021
  13. Antepartum SARS-CoV-2 infection and adverse birth outcomes in South African women. J Glob Health. 2022 Dec 03; 12:05050.
    View in: PubMed
    Score: 0,021
  14. Comparison of quantitative ultrasonography and dual X-ray absorptiometry for bone status assessment in South African children living with HIV. PLoS One. 2022; 17(10):e0276290.
    View in: PubMed
    Score: 0,021
  15. FCGR3A gene duplication, Fc?RIIb-232TT and Fc?RIIIb-HNA1a associate with an increased risk of vertical acquisition of HIV-1. PLoS One. 2022; 17(9):e0273933.
    View in: PubMed
    Score: 0,020
  16. Predictors of Cell-Associated Human Immunodeficiency Virus (HIV)-1 DNA Over 1 Year in Very Early Treated Infants. Clin Infect Dis. 2022 03 23; 74(6):1047-1054.
    View in: PubMed
    Score: 0,020
  17. Evaluating the performance of the GeneXpert HIV-1 qualitative assay as a consecutive test for a new early infant diagnosis algorithm in South Africa. S Afr Med J. 2021 09 02; 111(9):857-861.
    View in: PubMed
    Score: 0,019
  18. Switch to Efavirenz Attenuates Lipoatrophy in Girls With Perinatal HIV. J Pediatr Gastroenterol Nutr. 2021 01 01; 72(1):e15-e20.
    View in: PubMed
    Score: 0,018
  19. Quantifying the Dynamics of HIV Decline in Perinatally Infected Neonates on Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2020 10 01; 85(2):209-218.
    View in: PubMed
    Score: 0,018
  20. Behavioral Functioning and Quality of Life in South African Children Living with HIV on Antiretroviral Therapy. J Pediatr. 2020 12; 227:308-313.e2.
    View in: PubMed
    Score: 0,018
  21. Negative Diagnostic PCR Tests in School-Aged, HIV-Infected Children on Antiretroviral Therapy Since Early Life in Johannesburg, South Africa. J Acquir Immune Defic Syndr. 2020 04 01; 83(4):381-389.
    View in: PubMed
    Score: 0,017
  22. Bone Quality Measured Using Calcaneal Quantitative Ultrasonography Is Reduced Among Children with HIV in Johannesburg, South Africa. J Pediatr. 2019 12; 215:267-271.e2.
    View in: PubMed
    Score: 0,016
  23. Distinct epigenetic profiles in children with perinatally-acquired HIV on antiretroviral therapy. Sci Rep. 2019 07 19; 9(1):10495.
    View in: PubMed
    Score: 0,016
  24. Mitochondrial Impairment in Well-Suppressed Children with Perinatal HIV-Infection on Antiretroviral Therapy. AIDS Res Hum Retroviruses. 2020 01; 36(1):27-38.
    View in: PubMed
    Score: 0,016
  25. Educational delays among children living with perinatally-acquired HIV in Johannesburg, South Africa. AIDS Care. 2020 04; 32(4):438-444.
    View in: PubMed
    Score: 0,016
  26. 12-month outcomes of HIV-infected infants identified at birth at one maternity site in Johannesburg, South Africa: an observational cohort study. Lancet HIV. 2018 12; 5(12):e706-e714.
    View in: PubMed
    Score: 0,016
  27. Biomarkers of Aging in HIV-Infected Children on Suppressive Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2018 08 15; 78(5):549-556.
    View in: PubMed
    Score: 0,015
  28. Patterns of Growth, Body Composition, and Lipid Profiles in a South African Cohort of Human Immunodeficiency Virus-Infected and Uninfected Children: A Cross-Sectional Study. J Pediatric Infect Dis Soc. 2018 May 15; 7(2):143-150.
    View in: PubMed
    Score: 0,015
  29. Decreased bone turnover in HIV-infected children on antiretroviral therapy. Arch Osteoporos. 2018 Apr 05; 13(1):40.
    View in: PubMed
    Score: 0,015
  30. Dietary Inadequacies in HIV-infected and Uninfected School-aged Children in Johannesburg, South Africa. J Pediatr Gastroenterol Nutr. 2017 09; 65(3):332-337.
    View in: PubMed
    Score: 0,014
  31. Early age at start of antiretroviral therapy associated with better virologic control after initial suppression in HIV-infected infants. AIDS. 2017 Jan 28; 31(3):355-364.
    View in: PubMed
    Score: 0,014
  32. Efavirenz is associated with higher bone mass in South African children with HIV. AIDS. 2016 10 23; 30(16):2459-2467.
    View in: PubMed
    Score: 0,014
  33. Unusually High Calcaneal Speed of Sound Measurements inĀ Children with Small Foot Size. Ultrasound Med Biol. 2017 01; 43(1):357-361.
    View in: PubMed
    Score: 0,013
  34. Extent of disclosure: what perinatally HIV-infected children have been told about their own HIV status. AIDS Care. 2017 03; 29(3):378-386.
    View in: PubMed
    Score: 0,013
  35. Decreased Vigorous Physical Activity in School-Aged Children with Human Immunodeficiency Virus in Johannesburg, South Africa. J Pediatr. 2016 05; 172:103-9.
    View in: PubMed
    Score: 0,013
  36. Efavirenz-Based Antiretroviral Therapy Among Nevirapine-Exposed HIV-Infected Children in South Africa: A Randomized Clinical Trial. JAMA. 2015 Nov 03; 314(17):1808-17.
    View in: PubMed
    Score: 0,013
  37. Young age at start of antiretroviral therapy and negative HIV antibody results in HIV-infected children when suppressed. AIDS. 2015 Jun 01; 29(9):1053-60.
    View in: PubMed
    Score: 0,012
  38. Timing of maternal HIV testing and uptake of prevention of mother-to-child transmission interventions among women and their infected infants in Johannesburg, South Africa. J Acquir Immune Defic Syndr. 2014 Apr 15; 65(5):e170-8.
    View in: PubMed
    Score: 0,011
  39. Sex differences in responses to antiretroviral treatment in South African HIV-infected children on ritonavir-boosted lopinavir- and nevirapine-based treatment. BMC Pediatr. 2014 Feb 12; 14:39.
    View in: PubMed
    Score: 0,011
  40. Initiation of antiretroviral therapy before 6 months of age is associated with faster growth recovery in South African children perinatally infected with human immunodeficiency virus. J Pediatr. 2013 Jun; 162(6):1138-45, 1145.e1-2.
    View in: PubMed
    Score: 0,010
  41. Metabolic abnormalities and body composition of HIV-infected children on Lopinavir or Nevirapine-based antiretroviral therapy. Arch Dis Child. 2013 Apr; 98(4):258-64.
    View in: PubMed
    Score: 0,010
  42. Rapid development of antiretroviral drug resistance mutations in HIV-infected children less than two years of age initiating protease inhibitor-based therapy in South Africa. AIDS Res Hum Retroviruses. 2011 Sep; 27(9):945-56.
    View in: PubMed
    Score: 0,009
  43. Initial response to protease-inhibitor-based antiretroviral therapy among children less than 2 years of age in South Africa: effect of cotreatment for tuberculosis. J Infect Dis. 2010 Apr 15; 201(8):1121-31.
    View in: PubMed
    Score: 0,009
  44. Immune reconstitution inflammatory syndrome among HIV-infected South African infants initiating antiretroviral therapy. AIDS. 2009 Jun 01; 23(9):1097-107.
    View in: PubMed
    Score: 0,008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.